-
3
-
-
33748082979
-
Reduction of prostate cancer mortality in Ty-rol, Austria, after introduction of prostate-specific antigen testing
-
Oberaigner W, Horninger W, Klocker H, Schonitzer D, Stuhlinger W, Bartsch G: Reduction of prostate cancer mortality in Ty-rol, Austria, after introduction of prostate-specific antigen testing. Am J Epidemiol 2006; 164: 376-384.
-
(2006)
Am J Epidemiol
, vol.164
, pp. 376-384
-
-
Oberaigner, W.1
Horninger, W.2
Klocker, H.3
Schonitzer, D.4
Stuhlinger, W.5
Bartsch, G.6
-
4
-
-
0037014792
-
Overdi-agnosis due to prostate-specific antigen screening: Lessons from US prostate cancer incidence trends
-
Etzioni R, Penson DF, Legler JM, di Tom-maso D, Boer R, Gann PH, Feuer EJ: Overdi-agnosis due to prostate-specific antigen screening: Lessons from US prostate cancer incidence trends. J Natl Cancer Inst 2002; 94: 981-990.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 981-990
-
-
Etzioni, R.1
Penson, D.F.2
Legler, J.M.3
Di Tom-Maso, D.4
Boer, R.5
Gann, P.H.6
Feuer, E.J.7
-
5
-
-
0036166841
-
Prostate-specific antigen testing in black and white men: An analysis of medicare claims from 1991-1998
-
Etzioni R, Berry KM, Legler JM, Shaw P: Prostate-specific antigen testing in black and white men: An analysis of Medicare claims from 1991-1998. Urology 2002; 59: 251-255.
-
(2002)
Urology
, vol.59
, pp. 251-255
-
-
Etzioni, R.1
Berry, K.M.2
Legler, J.M.3
Shaw, P.4
-
6
-
-
39849100398
-
Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends
-
Telesca D, Etzioni R, Gulati R: Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Biometrics 2008; 64: 10-19.
-
(2008)
Biometrics
, vol.64
, pp. 10-19
-
-
Telesca, D.1
Etzioni, R.2
Gulati, R.3
-
7
-
-
18244398443
-
Detection of prostate cancer: The impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
-
Schröder FH: Detection of prostate cancer: The impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Can J Urol 2005; 12(suppl 1):2-6.
-
(2005)
Can J Urol
, vol.12
, Issue.SUPPL. 1
, pp. 2-6
-
-
Schröder, F.H.1
-
8
-
-
3343019398
-
The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise
-
PLCO Steering Committee
-
Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK, PLCO Steering Committee: The Prostate, Lung, Colon, and Ovarian (PLCO) Cancer Screening Trial: Status and promise. Urol Oncol 2004; 22: 358-361.
-
(2004)
Urol Oncol
, vol.22
, pp. 358-361
-
-
Andriole, G.L.1
Reding, D.2
Hayes, R.B.3
Prorok, P.C.4
Gohagan, J.K.5
-
9
-
-
0037285844
-
Trends in prostate cancer incidence and mortality: An analysis of mortality change by screening intensity
-
Coldman AJ, Phillips N, Pickles TA: Trends in prostate cancer incidence and mortality: An analysis of mortality change by screening intensity. CMAJ 2003; 168: 31-35.
-
(2003)
CMAJ
, vol.168
, pp. 31-35
-
-
Coldman, A.J.1
Phillips, N.2
Pickles, T.A.3
-
10
-
-
20944431913
-
The National Prostate Cancer Register in Sweden 1998-2002: Trends in incidence, treatment and survival
-
DOI 10.1080/00365590510007793
-
Varenhorst E, Garmo H, Holmberg L, Adolfsson J, Damber JE, Hellström M, Hugosson J, Lundgren R, Stattin P, Törnblom M, Johansson JE: The National Prostate Cancer Register in Sweden 1998-2002: Trends in incidence, treatment and survival. Scand J Urol Nephrol 2005; 39: 117-123. (Pubitemid 40632325)
-
(2005)
Scandinavian Journal of Urology and Nephrology
, vol.39
, Issue.2
, pp. 117-123
-
-
Varenhorst, E.1
Garmo, H.2
Holmberg, L.3
Adolfsson, J.4
Damber, J.-E.5
Hellstrom, M.6
Hugosson, J.7
Lundgrend, R.8
Stattin, P.9
Tornblom, M.10
Johansson, J.-E.11
-
11
-
-
0346997972
-
Epidemiology of prostate cancer
-
Crawford ED: Epidemiology of prostate cancer. Urology 2003; 62: 3-12.
-
(2003)
Urology
, vol.62
, pp. 3-12
-
-
Crawford, E.D.1
-
12
-
-
38649117599
-
Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy
-
Katalinic A, Rawal R: Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2008; 107: 427-430.
-
(2008)
Breast Cancer Res Treat
, vol.107
, pp. 427-430
-
-
Katalinic, A.1
Rawal, R.2
-
13
-
-
3042700097
-
Mortality in relation to smoking: 50 years' observations on male British doctors
-
Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
-
(2004)
BMJ
, vol.328
, pp. 1519
-
-
Doll, R.1
Peto, R.2
Boreham, J.3
Sutherland, I.4
-
14
-
-
34547136177
-
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical radical prostatectomy in European men
-
Gallina A, Karakiewicz PI, Hutterer GC, Chun FK, Briganti A, Walz J, Antebi E, Shariat SF, Suardi N, Graefen M, Erbersdobler A, Salonia A, Rigatti P, Huland H, Montorsi F: Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical radical prostatectomy in European men. Int J Cancer 2007; 121: 791-795.
-
(2007)
Int J Cancer
, vol.121
, pp. 791-795
-
-
Gallina, A.1
Karakiewicz, P.I.2
Hutterer, G.C.3
Chun, F.K.4
Briganti, A.5
Walz, J.6
Antebi, E.7
Shariat, S.F.8
Suardi, N.9
Graefen, M.10
Erbersdobler, A.11
Salonia, A.12
Rigatti, P.13
Huland, H.14
Montorsi, F.15
-
15
-
-
34247871540
-
Development of obesity in Germany - Prevalence, determinants and perspectives
-
Prugger C, Keil U: Development of obesity in Germany - prevalence, determinants and perspectives. Dtsch Med Wochenschr 2007; 132: 892-897.
-
(2007)
Dtsch Med Wochenschr
, vol.132
, pp. 892-897
-
-
Prugger, C.1
Keil, U.2
-
16
-
-
34548277030
-
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: Results of the EUROCARE-4 study
-
EUROCARE Working Group
-
Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M, EUROCARE Working Group: Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: Results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773-783.
-
(2007)
Lancet Oncol
, vol.8
, pp. 773-783
-
-
Berrino, F.1
De Angelis, R.2
Sant, M.3
Rosso, S.4
Bielska-Lasota, M.5
Coebergh, J.W.6
Santaquilani, M.7
-
17
-
-
34548232762
-
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data
-
DOI 10.1016/S1470-2045(07)70246-2, PII S1470204507702462
-
Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I, EUROCARE-4 Working Group: Recent cancer survival in Europe: A 2000-2002 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 752-753, 784-796. (Pubitemid 47321601)
-
(2007)
Lancet Oncology
, vol.8
, Issue.9
, pp. 784-796
-
-
Verdecchia, A.1
Francisci, S.2
Brenner, H.3
Gatta, G.4
Micheli, A.5
Mangone, L.6
Kunkler, I.7
-
18
-
-
77950133837
-
Neoadjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
-
Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD: Neoadjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev 2006; 4:CD006019.
-
(2006)
Cochrane Database Syst Rev
, vol.4
-
-
Kumar, S.1
Shelley, M.2
Harrison, C.3
Coles, B.4
Wilt, T.J.5
Mason, M.D.6
-
19
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
DOI 10.1093/annonc/mdl498
-
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592. (Pubitemid 46359643)
-
(2007)
Annals of Oncology
, vol.18
, Issue.3
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
Heanue, M.4
Colombet, M.5
Boyle, P.6
|